Cigna Group $CI Shares Bought by Maj Invest Holding A S

Maj Invest Holding A S lifted its stake in Cigna Group (NYSE:CI) by 13.6% during the second quarter, HoldingsChannel reports. The fund owned 443,993 shares of the health services provider’s stock after purchasing an additional 53,240 shares during the quarter. Cigna Group comprises approximately 5.6% of Maj Invest Holding A S’s holdings, making the stock its 7th biggest position. Maj Invest Holding A S’s holdings in Cigna Group were worth $122,399,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Legacy Wealth Management LLC MS increased its position in Cigna Group by 9.3% in the 2nd quarter. Legacy Wealth Management LLC MS now owns 907 shares of the health services provider’s stock worth $250,000 after purchasing an additional 77 shares during the last quarter. Affinity Capital Advisors LLC raised its position in Cigna Group by 39.3% during the second quarter. Affinity Capital Advisors LLC now owns 1,348 shares of the health services provider’s stock valued at $380,000 after acquiring an additional 380 shares in the last quarter. Valeo Financial Advisors LLC lifted its stake in Cigna Group by 13.5% in the second quarter. Valeo Financial Advisors LLC now owns 3,314 shares of the health services provider’s stock valued at $914,000 after acquiring an additional 395 shares during the last quarter. Chesley Taft & Associates LLC grew its position in Cigna Group by 0.8% in the second quarter. Chesley Taft & Associates LLC now owns 8,669 shares of the health services provider’s stock worth $2,390,000 after acquiring an additional 65 shares in the last quarter. Finally, Wilsey Asset Management Inc. increased its stake in shares of Cigna Group by 2.1% during the 2nd quarter. Wilsey Asset Management Inc. now owns 123,645 shares of the health services provider’s stock worth $34,086,000 after purchasing an additional 2,601 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 222,213 shares of company stock worth $64,751,950 over the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CI. UBS Group upped their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Morgan Stanley increased their price objective on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Wells Fargo & Company boosted their target price on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $336.00 to $307.00 in a research note on Tuesday. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Stock Performance

CI opened at $281.95 on Friday. The stock has a market cap of $74.50 billion, a PE ratio of 11.67, a P/E/G ratio of 0.97 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The stock’s 50 day simple moving average is $286.00 and its 200-day simple moving average is $281.20.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.